Co-expression of tissue factor, TROP2, and NECTIN4 in primary and matched metastatic cervical cancer lesions
Background: Early detection of cervical cancer (CC) generally leads to favorable prognosis; however, survival rates drop significantly for late-stage or recurrent disease with limited treatment options. Antibody-drug conjugates (ADCs) show promise across multiple cancers but remain sparsely explored...
Saved in:
| Main Authors: | Marit L. Ulvang, Oda Fløtre Kvile, Hege F. Berg, Kathrine Woie, Ingfrid S. Haldorsen, Alessandro D. Santin, Bjørn I. Bertelsen, Camilla Krakstad, Mari Kyllesø Halle |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Series: | Translational Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523325001846 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeted therapeutic strategies for Nectin-4 in breast cancer: Recent advances and future prospects
by: Yufei Wang, et al.
Published: (2025-02-01) -
Laryngeal Squamous Cell Carcinoma Is Characterized by a Stronger Expression of Nectin-4 Compared to Nectin-2
by: Matej Maršić, et al.
Published: (2025-04-01) -
Research hotspots and frontier analysis of the novel immune checkpoint Nectin-4
by: Yu Qiao, et al.
Published: (2025-12-01) -
Progress of Clinical Research on Trop2 in Solid Tumors
by: Ying ZHANG, et al.
Published: (2025-01-01) -
Nectin4‐targeted molecular imaging in solid tumors: Current status and future perspectives
by: Yongshun Liu, et al.
Published: (2025-06-01)